## DAY: Dayforce, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -2.1% below STRENGTH zone (4.0-10.0%); PEG 1.09 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($68.65)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. JPMorgan Chase & Co. Has $26.14 Million Holdings in Dayforce, Inc. $DAY**
- Source: MarketBeat | 20251204T111120 | Somewhat-Bearish | Relevance: 100%
- JPMorgan Chase & Co. reduced its stake in Dayforce, Inc. by 11.8%, selling 63,427 shares, leaving it with holdings valued at $26.14 million. Despite the reduction by JPMorgan, the company's stock has an average "Hold" rating from Wall Street analysts with a consensus price target of $70.36. Dayforce recently missed its quarterly EPS estimates, reporting $0.37 against an expected $0.56, though revenue increased by 9.5%.

**2. Q3 Earnings Roundup: BlackLine (NASDAQ:BL) And The Rest Of The Finance and HR Software Segment**
- Source: Yahoo Finance | 20251204T223500 | Neutral | Relevance: 63%
- This article reviews the Q3 earnings for BlackLine (NASDAQ:BL) and other finance and HR software companies. It highlights BlackLine's slower quarter despite meeting revenue expectations, contrasting with Marqeta (NASDAQ:MQ) which reported strong year-on-year revenue growth and outperformed analyst expectations. The roundup also covers Dayforce (NYSE:DAY), Paychex (NASDAQ:PAYX), and Paylocity (NASDAQ:PCTY), detailing their Q3 performances and market reactions.

**3. Q3 Earnings Roundup: BlackLine (NASDAQ:BL) And The Rest Of The Finance and HR Software Segment**
- Source: Barchart.com | 20251205T053038 | Neutral | Relevance: 63%
- This article provides a Q3 earnings roundup for the finance and HR software segment, focusing on BlackLine (NASDAQ:BL) and its peers. While BlackLine reported slower revenue growth and customer decline, Marqeta (NASDAQ:MQ) stood out with significant revenue and EBITDA beats. The overview also touches on Dayforce (NYSE:DAY), Paychex (NASDAQ:PAYX), and Paylocity (NASDAQ:PCTY) performance, alongside a broader market update.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 74.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Price (T.Rowe) Assoc: 15.5% (-0.9%)
- Capital Internationa: 12.0% (-6.6%)
- Vanguard Group Inc: 10.8% (-1.7%)
- Edgepoint Investment: 10.7% (+5.5%)
- Blackrock Inc.: 6.6% (+7.9%)

### Key Risks

1. Elevated short interest (12.6%): bears positioning against stock.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.09 suggests fair value with growth premium. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.1B |
| Beta | 1.20 |
| 52W Range | $48.01 - $75.14 |
| Short Interest | 12.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.09 |
| Forward P/E | 25.3 |
| Current P/E | 30.6 |
| YoY Growth | 20.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -0.7% to -2.1% (-1.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.1pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60. Elevated volume (1.7x 20MA), institutional activity likely. OFD pattern: -SLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.10% (CS: 37) | Weak |
| RSI_14 | 59.8 | Neutral |
| MACD Histogram | -0.01 | Bearish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 1.005x | Above |
| vs SMA200 | 1.120x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $69.07
- **Stop Loss:** $68.65 (0.6% risk)
- **Target:** $69.49 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 2380
- **Position Value:** $164,386.60
- **Portfolio %:** 164.39%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-11 (Est: $0.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.55 | $0.37 | -33.2% |
| 2025Q2 | $0.53 | $0.61 | +16.1% |
| 2025Q1 | $0.54 | $0.58 | +6.9% |
| 2024Q4 | $0.45 | $0.60 | +34.8% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*